NON-INVASIVE VENTILATION (NIV)
Effects on Respiratory Mechanics
|
Mechanism |
Effect |
|
Inspiratory pressure support |
↓ Work of breathing |
|
Positive end-expiratory pressure (PEEP/EPAP) |
↑ FRC, ↓ atelectasis |
|
Alveolar recruitment |
↑ Oxygenation |
|
Improved tidal volume |
↓ PaCO₂ |
|
Reduced respiratory muscle load |
Prevents fatigue |
Cardiovascular Effects
|
Effect |
Mechanism |
|
↓ Preload |
↑ Intrathoracic pressure |
|
↓ LV afterload |
↓ Transmural pressure |
|
Beneficial in cardiogenic pulmonary edema |
Improves cardiac output |
### Excessive pressure → hypotension
TYPES / MODES OF NIV
A. CPAP (Continuous Positive Airway Pressure)
Single continuous pressure throughout respiratory cycle
•Prevents alveolar collapse
Uses
✔ Cardiogenic pulmonary edema
✔ Obstructive sleep apnea
✔ Mild hypoxemic respiratory failure
Standard Starting CPAP
|
Parameter |
Initial Setting |
|
CPAP pressure |
5 -10 cm H₂O(↑ CPAP by 2 cm H₂O) |
|
FiO₂ |
Start 0.4–0.6, titrate to SpO₂ |
|
Interface |
Oronasal mask preferred |
|
Target SpO₂ |
92–96% (88–92% in COPD) |
BiPAP (Bilevel Positive Airway Pressure)
Two pressure levels:
|
Parameter |
Function |
|
IPAP |
Inspiratory support → ↑ VT, ↓ PaCO₂ |
|
EPAP |
Equivalent to PEEP → oxygenation |
Pressure Support (PS) = IPAP – EPAP
Advanced Modes (ICU Ventilators)
• PSV-NIV
• NIV-SIMV (rare)
• AVAPS (Average Volume Assured Pressure Support)
• iVAPS
Used mainly in chronic hypercapnic respiratory failure
INTERFACES USED IN NIV
|
Interface |
Advantages |
Disadvantages |
|
Nasal mask |
Comfort, speech |
Mouth leak |
|
Oronasal (full-face) |
Most common, effective |
Claustrophobia |
|
Total face mask |
↓ pressure sores |
Air leak |
|
Helmet NIV |
Better tolerance |
CO₂ rebreathing, noise |
—> Helmet NIV increasingly used in ARDS (e.g., COVID)
INDICATIONS
A. STRONG EVIDENCE / GOLD-STANDARD INDICATIONS
1. Acute Exacerbation of COPD (AECOPD)
Criteria
• pH < 7.35
• PaCO₂ > 45 mmHg
• Moderate–severe dyspnea
Guidelines: GOLD, ERS/ATS → Class I recommendation
2. Acute Cardiogenic Pulmonary Edema
Mechanism
• ↓ Preload
• ↓ LV afterload
• Recruits alveoli
B. MODERATE EVIDENCE INDICATIONS
3. Hypoxemic Respiratory Failure (Selected)
• Pneumonia (carefully selected)
• Early ARDS (PaO₂/FiO₂ > 150)
• Immunocompromised patients
High failure rates → close monitoring mandatory
4. Post-Extubation Respiratory Failure
• Especially in COPD, CHF
• Prophylactic NIV reduces re-intubation
5. Weaning Facilitation
- Difficult weaning in COPD
• NIV after extubation prevents failure
CHRONIC USE INDICATIONS
• Obesity hypoventilation syndrome
• Neuromuscular diseases (ALS, MG, DMD)
• Chest wall deformities
• Stable chronic hypercapnic COPD
CONTRAINDICATIONS
A. ABSOLUTE
- Cardiac or respiratory arrest
Inability to protect airway
Severe encephalopathy (GCS < 8)
Active vomiting / GI bleeding
Facial trauma or surgery
Uncontrolled agitation
B. RELATIVE
Hemodynamic instability
Excessive secretions
Severe hypoxemia (P/F < 100)
Recent upper GI surgery
INITIATION OF NIV – STEPWISE
A. Patient Selection (MOST IMPORTANT)
Ideal patient:
✔ Awake
✔ Cooperative
✔ Hemodynamically stable
✔ Moderate respiratory distress
✔ Able to clear secretions
B. Initial Settings (BiPAP)
|
Parameter |
Starting Value |
|
IPAP |
10–12 cmH₂O |
|
EPAP |
4–6 cmH₂O |
|
RR backup |
10–14/min |
|
FiO₂ |
Target SpO₂ 88–92% (COPD), 92–96% (others) |
Gradually titrate:
• IPAP ↑ to improve VT & CO₂
• EPAP ↑ for oxygenation
MONITORING DURING NIV
A. Clinical
• RR ↓
• Accessory muscle use ↓
• Dyspnea ↓
• Mental status improves
B. Gas Exchange
ABG at 1–2 hours
Success indicators:
✔ pH ↑
✔ PaCO₂ ↓
✔ PaO₂ ↑
PREDICTORS OF NIV SUCCESS vs FAILURE
A. Predictors of SUCCESS
✔ pH improves within 1–2 hrs
✔ RR decreases
✔ Patient comfortable
✔ Good mask fit
✔ Stable hemodynamics
B. Predictors of FAILURE
HACOR Score for Predicting NIV Failure
HACOR =
- H → Heart rate
- A → Acidosis (pH)
- C → Consciousness (GCS)
- O → Oxygenation (PaO₂/FiO₂ ratio)
- R → Respiratory rate
TOTAL SCORE
- Minimum = 0
- Maximum = 26
INTERPRETATION
|
HACOR Score |
Interpretation |
Clinical Action |
|
≤5 |
Low risk of NIV failure |
Continue NIV |
|
>5 |
High risk of NIV failure |
Consider early intubation |
|
>8–10 |
Very high risk |
Strong indication for intubation |
Cut-off ≥5 at 1 hour of NIV is the most commonly used threshold.
TIMING OF ASSESSMENT
- Baseline (before NIV)
- After 1 hour of NIV → MOST PREDICTIVE
- Repeat at 12 hours and 24 hours
- HACOR is NOT a replacement for clinical judgment
CLINICAL APPLICATION
Indications for using HACOR
- NIV in:
- ARDS
- Pneumonia
- Early COVID hypoxemia
- Immunocompromised patients
When NOT reliable
- Hypercapnic respiratory failure (e.g., COPD exacerbation)
- Sedated patients (GCS unreliable)
- Hemodynamic instability
HACOR vs ROX INDEX
|
Feature |
HACOR |
ROX Index |
|
Modality |
NIV |
HFNC |
|
Components |
5 (multi-system) |
3 (SpO₂/FiO₂, RR) |
|
Best timing |
1 hr |
2–12 hr |
## Delay in intubation ↑ mortality
COMPLICATIONS OF NIV
|
Complication |
Mechanism |
|
Aspiration |
Loss of airway reflex |
|
Pressure sores |
Mask pressure |
|
Gastric distension |
Air swallowing |
|
Barotrauma |
High pressures |
|
Eye irritation |
Air leak |
|
Hypotension |
↓ Preload |
NIV IN ARDS – CONTROVERSIAL BUT IMPORTANT
• NIV failure common in moderate–severe ARDS
• Best outcomes when:
– P/F > 150
– Early initiation
– Helmet NIV preferred
# Intubate early if no rapid improvement
WHEN TO INTUBATE (DO NOT DELAY)
Immediate intubation if:
• Cardiac arrest
• Severe hypoxemia
• Airway compromise
• NIV failure at 1–2 hrs
How to WEANING FROM NON-INVASIVE VENTILATION (NIV)
WHEN TO CONSIDER NIV WEANING (READINESS CRITERIA)
A. Clinical Stability
✔ Awake, alert, cooperative
✔ Hemodynamically stable (no/inotrope minimal)
✔ RR ≤ 25/min
✔ No severe accessory muscle use
✔ Minimal dyspnea (Borg ≤ 3)
B. Gas Exchange Targets
|
Parameter |
Target |
|
SpO₂ |
≥ 90% (COPD: 88–92%) |
|
PaO₂ |
≥ 60 mmHg |
|
FiO₂ |
≤ 0.4 |
|
pH |
≥ 7.35 |
|
PaCO₂ |
Stable or improving |
C. Ventilator Settings (Low Support)
|
Parameter |
Acceptable |
|
IPAP |
≤ 10–12 cmH₂O |
|
EPAP |
≤ 5–6 cmH₂O |
|
Backup rate |
Off or minimal |
Strategy 1: Gradual Reduction of NIV Duration (Most Common)
Principle: Increase spontaneous breathing time off NIV
|
Day |
NIV Usage |
|
Day 1 |
Continuous NIV except meals |
|
Day 2 |
NIV at night + intermittent daytime |
|
Day 3 |
Night-only NIV |
|
Day 4 |
Stop NIV |
✔ Preferred in COPD, AHF, hypercapnic failure
Strategy 2: Gradual Reduction of NIV Pressure Support
Stepwise decrease in IPAP
|
Step |
Action |
|
Step 1 |
Reduce IPAP by 2 cmH₂O every 6–12 h |
|
Step 2 |
Maintain EPAP |
|
Step 3 |
When IPAP ≤ 8–10 → trial off NIV |
✔ Useful in pressure-dependent patients
Feeding a Patient on Non-Invasive Ventilation (NIV)
Core Principles
- NIV ≠ absolute contraindication to enteral feeding
- Aim to maintain nutrition without increasing aspiration risk or NIV failure
DO NOT feed if:
- GCS < 13
- Active vomiting
- Copious secretions
- Severe hypoxemia or hypercapnic encephalopathy
B. NIV Factors
|
Factor |
Safe Feeding Range |
|
IPAP |
≤ 20 cmH₂O |
|
EPAP |
≤ 8–10 cmH₂O |
|
Mask fit |
Minimal leak |
|
NIV tolerance |
Stable for ≥ 6–12 h |
High pressures ↑ gastric insufflation & aspiration risk
Route of Feeding on NIV
Oral Feeding (Preferred if feasible)
- Allow small, slow meals Keep head elevated ≥45°.Restart NIV immediately after meals except in aerophagia,Marked gastric distension
Why NIV is needed immediately after meals
Pathophysiology
After meals:
- ↑ Oxygen consumption,↑ CO₂ production,↑ Diaphragmatic splinting due to gastric distension,↑ Work of breathing
High-risk patients (COPD, OHS, neuromuscular disease) may decompensate rapidly if NIV is delayed.
B. Enteral Feeding (Most ICU Patients)
1️⃣ Nasogastric Tube (NGT)
Most commonly used
Problems
- Mask leak around tube,Gastric distension,Aspiration risk
Risk reduction
- Use fine-bore (8–10 Fr) NGT,Prefer continuous feeding,Elevate head end 30–45°
2️⃣ Post-Pyloric Feeding (Nasojejunal) – BEST for High Risk
Preferred when available
Indications
- High aspiration risk
- Poor gastric emptying
- High NIV pressures
- Recurrent feed intolerance
– ESPEN & SCCM recommend post-pyloric feeding if NIV > 48 h(always recheck current recommendations)
Q.How NIV decreases afterload
1️⃣ Key Concept: What Is LV Afterload?
LV afterload ≈ LV transmural systolic pressure
LV afterload=PLV −Pintrathoracic
Where:
- PLV = intracavitary LV systolic pressure
- Pintrathoracic ≈ pleural pressure
It is the pressure the LV must generate to eject blood
2️⃣ NIV Increases Intrathoracic Pressure
- CPAP / EPAP → positive pressure throughout respiratory cycle
- IPAP (in BiPAP) → intermittent higher positive pressure during inspiration
3️⃣ How Increased Intrathoracic Pressure ↓ LV Afterload
A. Reduction in LV Transmural Pressure
LV transmural pressure=PLV −Ppleural
When NIV increases pleural pressure:
- External pressure on LV rises
- LV does not need to generate as high intracavitary pressure
- → Afterload decreases
B. Reduction in Aortic Transmural Pressure
- Aorta lies within thorax
- Increased intrathoracic pressure:
- Raises external pressure on aorta
- ↓ Aortic wall tension
Wall stress∝2hPtransmural ×r
Thus:
- ↓ pressure gradient between LV and aorta
- ↓ resistance to LV ejection
CPAP vs BiPAP – Afterload Effect
|
Mode |
Afterload Reduction |
|
CPAP |
Continuous afterload reduction |
|
BiPAP |
Afterload reduction + inspiratory unloading |
Both reduce afterload via EPAP component
GUIDELINES REFERENCED
• ERS/ATS NIV Guidelines
• GOLD COPD Guidelines
• Surviving Sepsis Campaign
• Harrison’s Principles of Internal Medicine
• NEJM / Intensive Care Medicine reviews
